Summit Therapeutics Inc Forecast and Target Price

Currently 7 wall-street analysts regularly analyze the financials of Summit Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 7 analysts offering 12-month price forecasts for Summit Therapeutics Inc (SMMT) have a share price target of $34.52. This median of share price forecast represents a 82.36% upside from the latest price of $18.93 as on 16.09.25.

Below is a chart showing the percentage difference between Summit Therapeutics Inc's share price and its median forecast price. As on 16.09.25, the difference is -20.06%